National Bank of Canada FI decreased its stake in shares of Waters Corporation (NYSE:WAT - Free Report) by 13.2% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 24,501 shares of the medical instruments supplier's stock after selling 3,733 shares during the quarter. National Bank of Canada FI's holdings in Waters were worth $9,030,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Olde Wealth Management LLC bought a new position in shares of Waters during the 1st quarter worth about $25,000. IFP Advisors Inc increased its holdings in shares of Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after purchasing an additional 44 shares during the period. Whipplewood Advisors LLC increased its holdings in shares of Waters by 5,200.0% during the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 104 shares during the period. CX Institutional bought a new position in shares of Waters during the 1st quarter worth about $75,000. Finally, Curat Global LLC bought a new position in shares of Waters during the 1st quarter worth about $80,000. Institutional investors own 94.01% of the company's stock.
Waters Stock Performance
NYSE WAT opened at $285.23 on Wednesday. The firm has a market cap of $16.98 billion, a price-to-earnings ratio of 25.72, a PEG ratio of 2.61 and a beta of 1.04. The company has a 50 day moving average of $322.84 and a 200-day moving average of $348.61. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56.
Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.93 by $0.02. The company had revenue of $771.33 million during the quarter, compared to analyst estimates of $745.96 million. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company's revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the business posted $2.63 earnings per share. On average, equities analysts forecast that Waters Corporation will post 12.86 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several research analysts have recently issued reports on the stock. Wells Fargo & Company dropped their price objective on shares of Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a report on Tuesday, August 5th. Jefferies Financial Group set a $385.00 price objective on shares of Waters and gave the stock a "buy" rating in a report on Monday, August 4th. Robert W. Baird dropped their price target on shares of Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Scotiabank reissued a "sector outperform" rating and issued a $465.00 price target on shares of Waters in a research report on Friday, July 11th. Finally, Bank of America increased their price target on shares of Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Ten research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $378.73.
Read Our Latest Stock Analysis on WAT
Waters Company Profile
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access